Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Familial melanoma (FM) is a rare inherited form of melanoma characterized by development of histologically confirmed melanoma in two first degrees relatives or more relatives in an affected family.
Biomarker and diagnostic research for familial melanoma has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered. Interventions under study include other interventions. Pipeline includes 1 NA. Research is primarily sponsored by academic and government institutions.
60 publications have been identified in PubMed for familial melanoma. Research spans Epidemiology / Natural History (37%), Review / Meta-Analysis (23%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 22 | 37% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 14 | 23% |
Patient case studies | 9 | 15% |
Laboratory research | 9 | 15% |
Testing and diagnosis research | 2 | 3% |
Clinical study results | 2 | 3% |
Other research | 1 | 2% |
New treatment approaches | 1 | 2% |
Chen K (2026). [PMID: 41498535](https://pubmed.ncbi.nlm.nih.gov/41498535/). *Mol Genet Genomic Med*. [Case Report / Case Series]
Ragnarsson KA (2026). [PMID: 41712014](https://pubmed.ncbi.nlm.nih.gov/41712014/). *Fam Cancer*. [Case Report / Case Series]
Garza-Rodríguez ML (2026). [PMID: 42194989](https://pubmed.ncbi.nlm.nih.gov/42194989/). *Genes (Basel)*. [Epidemiology / Natural History]
Parkhurst ES (2026). [PMID: 42126713](https://pubmed.ncbi.nlm.nih.gov/42126713/). *Fam Cancer*. [Basic Science / Preclinical]
Querido I (2026). [PMID: 40605265](https://pubmed.ncbi.nlm.nih.gov/40605265/). *Clin Genet*. [Epidemiology / Natural History]
McCrary JM (2026). [PMID: 41688774](https://pubmed.ncbi.nlm.nih.gov/41688774/). *Eur J Hum Genet*. [Epidemiology / Natural History]
Leite SJ (2026). [PMID: 42180414](https://pubmed.ncbi.nlm.nih.gov/42180414/). *Gynecol Oncol Rep*. [Case Report / Case Series]
Siddiqui FS (2026). [PMID: 40811605](https://pubmed.ncbi.nlm.nih.gov/40811605/). *Unknown Journal*. [Epidemiology / Natural History]
Goldstein AM (2026). [PMID: 42201696](https://pubmed.ncbi.nlm.nih.gov/42201696/). *JAMA Dermatol*. [Epidemiology / Natural History]
DiNardo CD (2026). [PMID: 41686515](https://pubmed.ncbi.nlm.nih.gov/41686515/). *Cancer*. [Epidemiology / Natural History]